Business - September 29, 2022
Q&A: Kaiku Health – from startup to acquisition
Two years ago Finnish health tech company Kaiku Health was acquired by Elekta, the global leader in radiotherapy technology. NLS asked Lauri Sippola, co-founder and CEO of Kaiku Health, about the company’s journey and his best advice to other entrepreneurs. Kaiku Health, based in Helsinki, is a great example of Finnish strengths in nurturing and […]
Biotech Business - August 31, 2022
Interview: Erik Manting, CEO, Mendus
Earlier this summer Immunicum announced a corporate rebranding and name change to Mendus and most recently the company reported financing commitments totaling up to 250 million SEK. NLS asked Erik Manting, CEO, about what lies ahead. What opportunities do you have on the market for cancer immunotherapy? “Many cancer patients today experience an initial treatment […]
Business - May 18, 2022
Business Interview: At the forefront of clinical cell therapy
XNK Therapeutics recently secured a private placement of 132 million SEK, enabling progress of the company’s development of new NK cell-based therapies. Since its foundation ten years ago, Swedish XNK Therapeutics has been developing novel autologous natural killer (NK) cell-based therapies targeting cancer. The company’s technology platform includes assets related to the investigational drug product […]
